Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukotriene B4

S W Crooks1, R A Stockley

  • 1Department of Medicine, Queen Elizabeth Hospital, Edgbastón, Birmingham, UK. stephen.crooks@virgin.net

The International Journal of Biochemistry & Cell Biology
|June 3, 1998
PubMed
Summary

Leukotriene B4 (LTB4) is a key inflammatory mediator. Inhibiting LTB4 may help treat inflammatory diseases involving neutrophil damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools.

Orphanet journal of rare diseases·2024
Same author

Bronchiectasis: A Progressive Phenotype of Chronic Obstructive Pulmonary Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Quantitative analysis of protease recognition by inhibitors in plasma using microscale thermophoresis.

Scientific reports·2016
Same author

Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study.

International journal of epidemiology·2016
Same author

Lung density associates with survival in alpha 1 antitrypsin deficient patients.

Respiratory medicine·2016
Same author

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

Thorax·2015

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • Leukotriene B4 (LTB4) is a pro-inflammatory mediator synthesized in myeloid cells from arachidonic acid.
  • Its synthesis is catalyzed by 5-lipoxygenase and leukotriene A4 hydrolase, and is upregulated by inflammatory signals like endotoxin, TNF, and interleukins.
  • 5-lipoxygenase activating protein is a crucial co-factor for 5-lipoxygenase activity.

Purpose of the Study:

  • To review the role of Leukotriene B4 in inflammation.
  • To discuss the potential of targeting LTB4 in inflammatory diseases.

Main Methods:

  • Literature review of studies on Leukotriene B4 synthesis, function, and inhibition.
  • Analysis of data from pharmacological inhibition studies.

Main Results:

  • LTB4 recruits and activates neutrophils, monocytes, and eosinophils.
  • LTB4 amplifies and prolongs tissue inflammation by stimulating pro-inflammatory cytokine production.
  • Elevated LTB4 levels correlate with disease activity in several inflammatory conditions.

Conclusions:

  • LTB4 plays a significant role in neutrophil-mediated tissue damage.
  • Pharmacological strategies targeting LTB4 production or action show promise for treating inflammatory diseases.

Related Experiment Videos